Sale!

Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management, 1ed

$17

: Lung Cancer: An Evidence-Based Approach to Multidisciplinary Managem…
: 30 MB

Book Title: Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management, 1ed

Details:

Author: Erin Alexis Gillaspie MD
Publisher: Elsevier; 1st edition
Release Year: 2024
Language: English
Format: PDF ( )
Page Count: 360
(ISBN) : 0323695736
Price in Amazon: $138.99
File Size: 30 MB

Overview

Care of the lung cancer patient―screening, diagnosis, and treatment―has undergone recent dramatic changes due to technologic and research-driven advances. Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management covers every aspect of this fast-changing field, including new screening guidelines, new practice standards, and new treatment advances that have led to higher survival rates. This practical, clinically oriented resource provides thorough, evidence-based coverage from experts in the field, including the increasingly important precision medicine approach in lung cancer planning and management.

  • Discusses key topics such as small cell and non-small cell lung cancers; immunotherapy, molecular cohorts including ROS1, BRAF, HER2, Met, and NTRK; oligometastatic disease; and more.
  • Covers individualized treatment plans for chemotherapy, radiotherapy, targeted biomarker-derived therapies, and new and emerging immunotherapies.
  • Provides excellent visual guidance throughout, including algorithms, pathology specimens, anatomic drawings, and  PET/CT and CT imaging for diagnosis and treatment planning.
  • Features “Top 5 Clinical Pearls” at the beginning of each chapter.
  • Shares the experience and knowledge of medical oncologists, radiation oncologists, surgical oncologists, and thoracic radiologists for a real-world tumor board perspective.

Review

Lung Cancer: An Evidence-Based Approach State-of-the-art, multidisciplinary guidance on lung cancer planning and management

Contents

. Lung cancer screening and prevention
. Lung cancer: Diagnostic techniques
. Histology and molecular testing
. Surgical considerations in lung cancer treatment
. Surgically resectable disease
. Oligometastatic disease
. Locally advanced non–small cell lung cancer
. First-line therapy
. Second-line therapy in advanced non–small cell lung cancer
. Epidermal growth factor receptor–mutated non–small cell lung cancer: a clinical approach
. Diagnosis and treatment of anaplastic lymphoma kinase (ALK) rearranged non−small cell lung cancer
. Other molecular cohorts including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS
. Immunotherapy
. Small cell lung cancer

Shopping Cart
Scroll to Top
Scroll to Top